<DOC>
	<DOCNO>NCT02398097</DOCNO>
	<brief_summary>Several study show poor immune response conventional influenza vaccine HIV-infected individual . This study conduct expect potent immunogenicity intradermal vaccine compare conventional intramuscular vaccine HIV-infected adult .</brief_summary>
	<brief_title>Conventional Vaccine Intradermal Vaccine Among HIV-infected Young Subjects</brief_title>
	<detailed_description>During 2011/2012 pre-influenza season , three vaccine use HIV-infected adult ( 18 60 year ) : inactivate intramuscular vaccine ( Agripal ) , reduced-content intradermal vaccine ( IDflu9μg ) standard-content intradermal vaccine ( IDflu15μg ) . Serum hemagglutination-inhibiting ( HI ) antibodies INF-γ ELISpot assay measured time vaccination 1 month vaccination . Adverse event record 7 day .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>HIVinfected individual immunize 2011/2012 influenza vaccine know allergy egg presentation febrile illness ≥37.5°C day vaccination history hypersensitivity reaction previous influenza vaccination vaccination within past one month use immunosuppressive agent recipient blood product immunoglobulins previous three month condition might interfere study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>